Researchers developed a micro-volume assay that quantifies T-cell responses and antibodies from fingertip blood, offering a ...
Morning Overview on MSN
Researchers map real-time signals that trigger T cell activation
A cluster of recent studies has sharpened the scientific picture of how T cells switch on, tracking the molecular signals ...
A T-cell test developed by Adaptive Biotechnologies could become the first commercially available test of its kind, and it may be more effective at detecting past COVID-19 infections than antibody ...
A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer after re-introduction into the body of a cancer patient. This simple ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results